NCT03516799

Brief Summary

The aim of the study is to innovatively extend acupuncture research in adult oncology to adolescents and young adults (AYA) by piloting a tailored acupuncture protocol for pain management in AYA in the Children's Hospital of Philadelphia (CHOP's) Center for Integrative Health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 23, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 4, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

August 13, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 8, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 8, 2019

Completed
Last Updated

December 18, 2019

Status Verified

December 1, 2019

Enrollment Period

1.2 years

First QC Date

March 23, 2018

Last Update Submit

December 17, 2019

Conditions

Keywords

pain management of adolescent and young adults with cancer

Outcome Measures

Primary Outcomes (4)

  • Acceptability of use of Acupuncture for pain management of AYA and associates

    Number of participants who report satisfaction and intention for future use through a qualitative semi-structured interview. ("How satisfied were you with the number of acupuncture sessions you received over the course of the study?"...."how likely would you be to continue to receive acupuncture in the future?")

    15 weeks

  • Number of acupuncture sessions completed

    Number of sessions participants complete and time between sessions, which will be logged by research team for feasibility.

    15 weeks

  • Number of participant-reported barriers to participating in acupuncture sessions for AYA who opt in

    Number of participants who report barriers to participation during qualitative semi-structured interview for feasibility. ("How difficult or inconvenient did you find going to your acupuncture appointment over the course of these past 10 weeks to be?")

    15 weeks

  • Incidence of patient-reported adverse events of AYA who opt in to acupuncture relative to those who opt out

    Limited report of acupuncture-related side effects which will be logged as patient reported outcomes ("did you experience any adverse events?") post-acupuncture sessions. Treatment-Related Adverse Events as Assessed by CTCAE v4.0, change from baseline in pain scores.

    15 weeks

Secondary Outcomes (1)

  • Acupuncture as a pain management tool

    15 weeks

Study Arms (2)

Acupuncture (ACU) Group

EXPERIMENTAL

The group of participants who opt in to acupuncture

Other: Acupuncture

Treatment-as-Usual (TAU) Group

NO INTERVENTION

The group of participants who enroll in the study but opt out of acupuncture (treatment-as-usual)

Interventions

Acupuncture is a method of Traditional Chinese Medicine that consists of the insertion of thin, sterile, FDA-approved disposable needles on specific acupuncture points (acupoints).

Acupuncture (ACU) Group

Eligibility Criteria

Age13 Years - 24 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Report a pain severity score of ≥ 4 in last 7 days on an 11-point (0-10) numerical rating scale and reports a pain distress score of ≥ 2 on a 5-point numerical rating scale
  • Males or females age 13 to 24 years
  • On treatment for cancer for at least one month or within two years of completing treatment
  • Not expected to be terminal within the next 6 months
  • Absence of infection or bleeding disorder
  • Physically and medically able to get to the acupuncture clinic
  • Able to read and write English

You may not qualify if:

  • Parents'guardians or subjects who, in the opinion of the investigator, may be non-compliant with the study schedules or procedures
  • Cognitive impairments that would limit AYA's ability to complete measures or to independently care for health as determined by medical team
  • Be primary parent/guardian of the AYA participant
  • Be able to read and write English
  • Cognitive impairments that would limit the parent/guardian's ability to complete measures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Interventions

Acupuncture Therapy

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Lisa Schwartz, PhD

    Children's Hospital of Philadelphia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Non-randomized trial across four time points at one study site
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 23, 2018

First Posted

May 4, 2018

Study Start

August 13, 2018

Primary Completion

November 8, 2019

Study Completion

November 8, 2019

Last Updated

December 18, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations